A detailed history of Ubs Asset Management Americas Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 598,730 shares of PACB stock, worth $969,942. This represents 0.0% of its overall portfolio holdings.

Number of Shares
598,730
Previous 296,771 101.75%
Holding current value
$969,942
Previous $1.11 Million 26.26%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.36 - $3.65 $410,664 - $1.1 Million
301,959 Added 101.75%
598,730 $820,000
Q4 2023

Feb 14, 2024

BUY
$5.97 - $10.36 $39,801 - $69,070
6,667 Added 2.3%
296,771 $2.91 Million
Q3 2023

Nov 13, 2023

SELL
$8.23 - $13.93 $4,814 - $8,149
-585 Reduced 0.2%
290,104 $2.42 Million
Q1 2023

May 15, 2023

BUY
$7.94 - $12.02 $116,662 - $176,609
14,693 Added 5.32%
290,689 $3.37 Million
Q4 2022

Feb 14, 2023

BUY
$5.67 - $11.2 $38,181 - $75,420
6,734 Added 2.5%
275,996 $2.26 Million
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $105,996 - $231,141
26,971 Added 11.13%
269,262 $1.56 Million
Q2 2022

Aug 12, 2022

SELL
$4.02 - $10.43 $179,078 - $464,625
-44,547 Reduced 15.53%
242,291 $1.07 Million
Q1 2022

May 16, 2022

BUY
$8.43 - $20.9 $577,016 - $1.43 Million
68,448 Added 31.34%
286,838 $2.61 Million
Q4 2021

Feb 14, 2022

BUY
$19.26 - $30.08 $292,520 - $456,855
15,188 Added 7.47%
218,390 $4.47 Million
Q3 2021

Nov 15, 2021

BUY
$24.86 - $35.02 $586,173 - $825,736
23,579 Added 13.13%
203,202 $5.19 Million
Q2 2021

Aug 16, 2021

BUY
$22.3 - $36.02 $257,988 - $416,715
11,569 Added 6.88%
179,623 $6.28 Million
Q1 2021

May 14, 2021

SELL
$26.38 - $51.15 $1.44 Million - $2.79 Million
-54,492 Reduced 24.49%
168,054 $5.6 Million
Q4 2020

Mar 01, 2021

BUY
$10.5 - $28.5 $1.03 Million - $2.81 Million
98,463 Added 79.35%
222,546 $5.77 Million
Q3 2020

Nov 13, 2020

BUY
$3.61 - $9.87 $20,984 - $57,374
5,813 Added 4.92%
124,083 $1.22 Million
Q2 2020

Aug 14, 2020

BUY
$2.65 - $4.03 $9,688 - $14,733
3,656 Added 3.19%
118,270 $408,000
Q1 2020

May 15, 2020

SELL
$2.36 - $5.26 $494,809 - $1.1 Million
-209,665 Reduced 64.66%
114,614 $350,000
Q4 2019

Feb 14, 2020

BUY
$4.6 - $5.57 $1.01 Million - $1.22 Million
219,484 Added 209.44%
324,279 $1.67 Million
Q3 2019

Nov 14, 2019

BUY
$4.99 - $6.16 $46,287 - $57,140
9,276 Added 9.71%
104,795 $540,000
Q2 2019

Aug 15, 2019

BUY
$5.92 - $7.41 $64,380 - $80,583
10,875 Added 12.85%
95,519 $0
Q1 2019

May 14, 2019

BUY
$6.8 - $7.4 $79,383 - $86,387
11,674 Added 16.0%
84,644 $0
Q4 2018

Feb 13, 2019

BUY
$3.99 - $7.82 $149,026 - $292,077
37,350 Added 104.86%
72,970 $539,000
Q3 2017

Nov 13, 2017

BUY
$3.2 - $5.57 $113,984 - $198,403
35,620
35,620 $0

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $364M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.